{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:20:31Z","timestamp":1790630431061,"version":"4.1.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The risk of cardiovascular events in patients with Rheumatoid Arthritis (RA) is disproportionately heightened as a result of systemic inflammation. The relative effect of autoimmune-associated citrullination on the structure and thrombotic potential of fibrin(ogen) remains unknown. We therefore compared indices of vascular function, inflammation, coagulation and fibrin clot composition in RA patients with healthy controls and evaluated parameter association with disease presence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Blood samples were collected from 30 RA patients and 30 age- and gender-matched healthy volunteers. Levels of serum amyloid A (SAA), c-reactive protein (CRP), soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vascular cell adhesion molecule 1 (sVCAM-1) was measured using a sandwich immunoassay. Whole blood coagulation was assessed using Thromboelastography (TEG\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ). Fibrin clot networks and fiber structure was investigated using Scanning Electron Microscopy. The detection and quantification of citrullination in formed fibrin clots was performed using a fluorescently labeled Citrulline monoclonal antibody with Fluorescence Wide Field Microscopy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Concentrations of SAA, CRP and ICAM-1 were significantly elevated in RA patients compared to controls. TEG parameters relating to coagulation initiation, rate of fibrin cross-linking, and time to reach maximum thrombus generation were attenuated in RA patients. Microscopic analysis revealed denser networks of thicker fibrin fibers in RA patients compared to controls and multiple citrullinated regions within fibrin clot structures in RA patients were present.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings provide novel evidence for the citrullination of fibrin within vasculature is more prominent in RA plasma compared to control plasma and plasma is more accessible than synovial fluid. Citrullinated fibrinogen could play a role as a determinant of thrombotic risk in RA patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2020.577523","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T01:20:52Z","timestamp":1607044852000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency"],"prefix":"10.3389","volume":"11","author":[{"given":"Johannes A.","family":"Bezuidenhout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantelle","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Tarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Kell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etheresia","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.026","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers","volume":"15","author":"Lopez-Mejias","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rincon","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross Talk Pathways Between Coagulation and Inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133523","article-title":"Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review","volume":"10","author":"Maino","year":"2015","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0220531","article-title":"Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis","volume":"14","author":"S\u00f6dergren","year":"2019","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1571342","article-title":"What Is the Biological and Clinical Relevance of Fibrin","volume":"42","author":"Litvinov","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)43435-1","article-title":"Binding of fibronectin by the acute phase reactant C-reactive protein","volume":"259","author":"Salonen","year":"1984","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-39056-x","article-title":"Serum amyloid A binds to fibrin (ogen), promoting fibrin amyloid formation","volume":"9","author":"Page","year":"2019","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.04.007","article-title":"Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis","volume":"126","author":"Kwasny-Krochin","year":"2010","journal-title":"Thromb Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1805-2","article-title":"Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis","volume":"32","author":"Pretorius","year":"2012","journal-title":"Rheumatol Int"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2014.06.006","article-title":"Chronic arthritis and cardiovascular disease: altered blood parameters give rise to a prothrombotic propensity","volume-title":"Semin Arthritis Rheum","author":"Beinsberger","year":"2014"},{"key":"B13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.30081","article-title":"Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcgamma receptor","volume":"63","author":"Sokolove","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.40035","article-title":"High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4","volume":"69","author":"Blachere","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cca.2019.10.033","article-title":"Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure","volume":"501","author":"Damiana","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.12.002","article-title":"Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin","volume":"401","author":"Okumura","year":"2009","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1254054","article-title":"The prothrombotic state in rheumatoid arthritis: an additive risk factor for adverse cardiovascular events","volume":"36","author":"Bisoendial","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.184","article-title":"Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis","volume":"8","author":"Hoppe","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206411","article-title":"The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease","volume":"75","author":"Myasoedova","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.21235","article-title":"Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states","volume":"52","author":"Aletaha","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.thromres.2017.04.005","article-title":"Blood clot parameters: Thromboelastography and scanning electron microscopy in research and clinical practice","volume":"154","author":"Pretorius","year":"2017","journal-title":"Thromb Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/01.mbc.0000198047.35010.77","article-title":"Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation","volume":"17","author":"Nielsen","year":"2006","journal-title":"Blood Coagul Fibrinolysis an Int J Haemost Thromb"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2804","article-title":"Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis","volume":"11","author":"Shen","year":"2015","journal-title":"Mol Med Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4134-y","article-title":"Can we predict thrombotic tendency in rheumatoid arthritis? A thromboelastographic analysis (with ROTEM)","volume":"37","author":"Turk","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker011","article-title":"Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis","volume":"50","author":"Rooney","year":"2011","journal-title":"Rheumatol (Oxford England)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1160\/TH14-01-0032","article-title":"Fibrin clot properties and their modulation in thrombotic disorders","volume":"112","author":"Undas","year":"2014","journal-title":"Thromb Haemost"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04629-8","article-title":"Assessment of hemostatic disturbances in women with established rheumatoid arthritis","volume":"38","author":"Vranic","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0116350","DOI":"10.1371\/journal.pone.0116350","article-title":"Physical determinants of fibrinolysis in single fibrin fibers","volume":"10","author":"Bucay","year":"2015","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: a posttranslational modification in health and disease","volume":"38","author":"Gyorgy","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0203214","DOI":"10.1371\/journal.pone.0203214","article-title":"Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3","volume":"13","author":"Damgaard","year":"2018","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/ar3585","article-title":"Citrullination of fibrinogen: generation of neoepitopes and enhancement of immunostimulatory properties","volume":"14","author":"Robinson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/art.40035","article-title":"High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4","volume":"69","author":"Blach\u00e8re","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/ar2478","article-title":"Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis","volume":"10","author":"Zhao","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin","volume":"166","author":"Masson-Bessiere","year":"2001","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B41","article-title":"Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis","volume":"33","author":"Hill","year":"2006","journal-title":"J Rheumatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/art.27597","article-title":"CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice","volume":"62","author":"Yue","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201517","article-title":"A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis","volume":"190","author":"Cordova","year":"2013","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011767","article-title":"A fibrin based model for rheumatoid synovitis","volume":"62","author":"Sanchez-Pernaute","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201906","article-title":"Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts","volume":"72","author":"Sanchez-Pernaute","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044743","article-title":"Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids","volume":"65","author":"Takizawa","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535790","article-title":"Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins","volume":"36","author":"Sebbag","year":"2006","journal-title":"Eur J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.48.30709","article-title":"Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin","volume":"271","author":"Tarcsa","year":"1996","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600162","article-title":"Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes","volume":"197","author":"Travers","year":"2016","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvn079","article-title":"Citrullinated fibrinogen inhibits thrombin-catalysed fibrin polymerization","volume":"144","author":"Nakayama-Hamada","year":"2008","journal-title":"J Biochem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1251-1","article-title":"Alterations of the thrombin generation profile in rheumatoid arthritis","volume":"41","author":"Kern","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-02-0091","article-title":"Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition","volume":"104","author":"Undas","year":"2010","journal-title":"Thromb Haemost"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh473","article-title":"The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis","volume":"44","author":"Chang","year":"2005","journal-title":"Rheumatol (Oxford England)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.chembiol.2018.03.002","article-title":"The Rheumatoid Arthritis-Associated Citrullinome","volume":"25","author":"Tilvawala","year":"2018","journal-title":"Cell Chem Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799504759","article-title":"Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research","volume":"18","author":"Yuri Gasparyan","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"Del Rincon","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.577523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T08:27:11Z","timestamp":1618561631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.577523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2020.577523"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.577523","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]},"article-number":"577523"}}